Huarong Sci-Tech Wins Multiple Awards at the 6th China Medical Device Innovation and Entrepreneurship Competition with Its Biodegradable Magnesium Alloy Products

The competition is organized byUnder the guidance of relevant departments of the China Association for Science and Technology (CAST) and the Ministry of Science and Technology,Hosted by the National Medical Device Industry Technology Innovation Alliance, the Administrative Committee of Tianjin Hi-Tech Industrial Development Zone, and the Tianjin Municipal Medical Products Administration, the event is themed “Addressing Practical Needs, Supporting the Translation of Clinical and Academic Research Achievements, and Emphasizing Technological Innovation and Innovation Services.” The competition consists of on-site roadshows and a Q&A session, with judges evaluating fromInnovation, Clinical and Social Value, Project Progress, Team, Risk AssessmentScores were assigned across five dimensions. Dozens of innovative projects competed side by side, with round after round of compelling presentations igniting a new wave of innovation in China’s medical device industry!

Huaron Kechuang's Orthopedic Product Manager and Orthopedic R&D Manager represented the company in the competition,Competing alongside numerous universities, research institutes, and corporate innovation teams, with“Biodegradable Magnesium Alloy Maxillofacial Plate and Screw System” Won the Second Prize in the Stomatology Special Session Competition,with“Biodegradable Magnesium Alloy Screws” won the second prize in the Orthopedic Devices category, and “Biodegradable Magnesium Alloy Maxillofacial Plate and Screw System” won the third prize in the Orthopedic Devices category.。

Innovative and creative projects emerged frequently at the competition, making it highly competitive. This marks VCBeat’s second participation in the Medical Device Innovation Competition, and alsoThe Fourth Award-Winning Project Since Entering the Competition, demonstrating that Sci-Tech Innovation’s persistent pursuit of innovation has been recognized, further strengthening its resolve and determination in this area. In 2023, the company accelerated its innovation efforts, with new products to be launched sequentially; please stay tuned for subsequent product announcements.

Kechuang Medical Group was founded in 2006. Guided by its mission to “make surgery simpler and life better,” the company has established a long-term strategic goal of “becoming a global leader in niche medical sectors, grounded in professionalism and driven by innovation.” Over the past 17 years, it has evolved into a high-tech medical group integrating research and development, manufacturing, and sales. Since its inception, the group has positioned itself with the strategy of “import substitution and original international innovation.” Focusing on the development of innovative technologies and materials, it addresses clinical pain points and patient needs. With microsurgery and orthopedics as its core research domains, and design innovation and material innovation as key technological pillars, the group has implemented systematic industrial layouts in both fields, overcoming critical technological bottlenecks and achieving significant breakthroughs. Throughout its development, the company has been honored with numerous titles by the government, including “National High-Tech Enterprise,” “Science and Technology Innovation Achievement Award under the Science and Technology Powerhouse Innovation Enterprise Cultivation Project,” “Specialized, Refined, Differential, and Innovative (SRDI) Enterprise,” “Leading Enterprise in Tianjin’s Strategic Emerging Industries,” and “Tianjin Gazelle Enterprise.”